Infectious Respiratory Disease Diagnostics Market Size, Demand, Report to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Infectious Respiratory Disease Diagnostics Market Size Analysis

Global Infectious Respiratory Disease Diagnostics Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Saliva
    1. By Value
  3. Nasopharyngeal Swabs (NPS)
    1. By Value
  4. Anterior Nasal Swabs
    1. By Value
  5. Blood
    1. By Value
  6. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassay
    1. By Value
  3. Molecular Diagnostics
    1. By Value
  4. Microbiology
    1. By Value
  5. Other technologies
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. COVID-19
    1. By Value
  3. Influenza
    1. By Value
  4. Respiratory Syncytial Virus (RSV)
    1. By Value
  5. Tuberculosis
    1. By Value
  6. Streptococcus Testing
    1. By Value
  7. Other Respiratory Disease Testing
    1. By Value
5. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Physician Offices
    1. By Value
  5. Other End Users
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Saliva
    1. By Value
  3. Nasopharyngeal Swabs (NPS)
    1. By Value
  4. Anterior Nasal Swabs
    1. By Value
  5. Blood
    1. By Value
  6. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassay
    1. By Value
  3. Molecular Diagnostics
    1. By Value
  4. Microbiology
    1. By Value
  5. Other technologies
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. COVID-19
    1. By Value
  3. Influenza
    1. By Value
  4. Respiratory Syncytial Virus (RSV)
    1. By Value
  5. Tuberculosis
    1. By Value
  6. Streptococcus Testing
    1. By Value
  7. Other Respiratory Disease Testing
    1. By Value
5. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Physician Offices
    1. By Value
  5. Other End Users
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Saliva
    1. By Value
  3. Nasopharyngeal Swabs (NPS)
    1. By Value
  4. Anterior Nasal Swabs
    1. By Value
  5. Blood
    1. By Value
  6. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassay
    1. By Value
  3. Molecular Diagnostics
    1. By Value
  4. Microbiology
    1. By Value
  5. Other technologies
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. COVID-19
    1. By Value
  3. Influenza
    1. By Value
  4. Respiratory Syncytial Virus (RSV)
    1. By Value
  5. Tuberculosis
    1. By Value
  6. Streptococcus Testing
    1. By Value
  7. Other Respiratory Disease Testing
    1. By Value
5. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Physician Offices
    1. By Value
  5. Other End Users
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Saliva
    1. By Value
  3. Nasopharyngeal Swabs (NPS)
    1. By Value
  4. Anterior Nasal Swabs
    1. By Value
  5. Blood
    1. By Value
  6. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassay
    1. By Value
  3. Molecular Diagnostics
    1. By Value
  4. Microbiology
    1. By Value
  5. Other technologies
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. COVID-19
    1. By Value
  3. Influenza
    1. By Value
  4. Respiratory Syncytial Virus (RSV)
    1. By Value
  5. Tuberculosis
    1. By Value
  6. Streptococcus Testing
    1. By Value
  7. Other Respiratory Disease Testing
    1. By Value
5. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Physician Offices
    1. By Value
  5. Other End Users
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables
  1. By Value
4. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Saliva
  1. By Value
3. Nasopharyngeal Swabs (NPS)
  1. By Value
4. Anterior Nasal Swabs
  1. By Value
5. Blood
  1. By Value
6. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Immunoassay
  1. By Value
3. Molecular Diagnostics
  1. By Value
4. Microbiology
  1. By Value
5. Other technologies
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. COVID-19
  1. By Value
3. Influenza
  1. By Value
4. Respiratory Syncytial Virus (RSV)
  1. By Value
5. Tuberculosis
  1. By Value
6. Streptococcus Testing
  1. By Value
7. Other Respiratory Disease Testing
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Physician Offices
  1. By Value
5. Other End Users
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables
    1. By Value
  4. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Saliva
    1. By Value
  3. Nasopharyngeal Swabs (NPS)
    1. By Value
  4. Anterior Nasal Swabs
    1. By Value
  5. Blood
    1. By Value
  6. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Immunoassay
    1. By Value
  3. Molecular Diagnostics
    1. By Value
  4. Microbiology
    1. By Value
  5. Other technologies
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. COVID-19
    1. By Value
  3. Influenza
    1. By Value
  4. Respiratory Syncytial Virus (RSV)
    1. By Value
  5. Tuberculosis
    1. By Value
  6. Streptococcus Testing
    1. By Value
  7. Other Respiratory Disease Testing
    1. By Value
5. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Physician Offices
    1. By Value
  5. Other End Users
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Infectious Respiratory Disease Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Koninklijke Philips N.V.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
NIHON KOHDEN CORPORATION
Thermos Fisher Scientific Inc.
Cardinal Health
F. Hoffmann-La Roche AG.
COSMED
Abbott Laboratories, Becton
Dickinson and Company
Smiths Group plc
Alere, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment